background image

Ophthalmology Clinical Trials

Find clinical trials for Ophthalmology. Search for oncology clinical trials in different cities and states across the United States.

Filter
1

A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products

Recruiting

Sponsor:

Hoffmann-La Roche

Location:

Quebec, Phoenix, Beverly Hills, Pasadenashow 25 more

Code:

NCT05476926

Conditions

Neovascular Age-related Macular Degeneration

Diabetic Macular Edema

Retinal Vein Occlusion

Branch Retinal Vein Occlusion

Central Retinal Vein Occlusion

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Faricimab

Port Delivery System with Ranibizumab

Stem Cell Ophthalmology Treatment Study II

Recruiting

Sponsor:

MD Stem Cells

Location:

Westport, Coral Springs

Code:

NCT03011541

Conditions

Retinal Disease

Age-Related Macular Degeneration

Retinitis Pigmentosa

Stargardt Disease

Optic Neuropathy

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Arm 1

IDE196 (Darovasertib) in Combination With Crizotinib as First-line Therapy in Metastatic Uveal Melanoma

Recruiting
PHASE2
PHASE3

Sponsor:

IDEAYA Biosciences

Location:

Scottsdale, La Jolla, Los Angeles, San Franciscoshow 25 more

Code:

NCT05987332

Conditions

Metastatic Uveal Melanoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

IDE196

Crizotinib

Pembrolizumab

Ipilimumab

Nivolumab

Study of IDE196 in Patients with Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions

Recruiting
PHASE1
PHASE2

Sponsor:

IDEAYA Biosciences

Location:

Los Angeles, San Francisco, New York, Durhamshow 5 more

Code:

NCT03947385

Conditions

Metastatic Uveal Melanoma

Cutaneous Melanoma

Colorectal Cancer

Other Solid Tumors

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

IDE196

Binimetinib

Crizotinib

Evaluation of Kamuvudine-8 in Subjects with Geographic Atrophy

Recruiting
PHASE1

Sponsor:

University of Kentucky

Location:

Lexington

Code:

NCT06164587

Conditions

Geographic Atrophy

Age-Related Macular Degeneration

Eligibility Criteria

Sex: All

Age: 50 - 70+

Healthy Volunteers: Not accepted

Interventions

K8

New Pediatric Patching Method to Improve Compliance

Recruiting

Sponsor:

Baylor College of Medicine

Location:

Houston

Code:

NCT02236351

Conditions

Amblyopia

Strabismus

Eligibility Criteria

Sex: All

Age: 0 - 7

Healthy Volunteers: Not accepted

Interventions

Pinch Patch/ flat Patch

Study of AR-14034 in Participants with Neovascular Age-Related Macular Degeneration (nAMD)

Recruiting
PHASE1
PHASE2

Sponsor:

Alcon Research

Location:

Mountain View, Pensacola, Saint Petersburg, Philadelphiashow 2 more

Code:

NCT05769153

Conditions

Neovascular Age-related Macular Degeneration (nAMD)

Eligibility Criteria

Sex: All

Age: 50+

Healthy Volunteers: Not accepted

Interventions

AR-14034 SR implant lower dose

Aflibercept Injection

Sham procedure

AR-14034 SR implant higher dose

(Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma

Recruiting
PHASE2

Sponsor:

IDEAYA Biosciences

Location:

Scottsdale, La Jolla, Los Angeles, Palo Altoshow 10 more

Code:

NCT05907954

Conditions

Uveal Melanoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Darovasertib

What are ophthalmology clinical trials?

What types of clinical trials are used for ophthalmology?

Participation in an ophthalmology clinical trial

Who can participate in a clinical trial for ophthalmology?

How to enroll in a ophthalmology clinical trial